Prot #XmAb5871-04: A Randomized, Double-Blinded, Placebo-Controlled Study of the Effect of XmAb®5871 on Systemic Lupus Erythematosus Disease Activity

Project: Research project

Project Details

StatusFinished
Effective start/end date9/13/169/13/19

Funding

  • PPD Investigator Services, LLC (Prot #XmAb5871-04)
  • Xencor, Inc. (Prot #XmAb5871-04)